TrialClinical pharmacology and therapeutics2020

Exposure-Response Analyses for Upadacitinib Efficacy and Safety in the Crohn's Disease CELEST Study and Bridging to the Extended-Release Formulation.

Mohamed-Eslam F Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.